![European Union Flag](https://medtechintelligence.com/wp-content/uploads/2017/10/EU-European-Union-Flag.jpg)
European Commission Adopts Common Specifications for High-Risk Diagnostics
The specifications set uniform and rigorous benchmarks for tests across the EU, with the goal of clarifying the requirements for market actors and protecting EU patients.
The specifications set uniform and rigorous benchmarks for tests across the EU, with the goal of clarifying the requirements for market actors and protecting EU patients.
FDA has issued a safety communication to alert patients and healthcare providers about the dangers of inappropriate use of NIPS tests.
This article discusses simple optical designs and common imaging techniques used in microfluidic enabled platforms. It will also suggest key elements to consider when deciding which optical set-up to employ for a given microfluidic application.
Diagnostic advances bode well for the imminent expansion of the global COVID-19 detection kits market, which is expected to be worth $8 billion by 2027.
Greater use of next generation sequencing can better prepare the world for future diseases and accelerate the adoption of precision care.
During the COVID-19 crisis, digital forces like artificial intelligence have assisted the healthcare industry to focus on patient care while achieving improved efficiency during treatments.
Anyone can read the regulation. The challenge is in how to apply it to your company’s structure and product line.
The PCR and real-time PCR molecular diagnostics was valued at $4 billion in 2019.
Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.
In order to meet the worldwide need for faster and affordable testing processes, companies must shift goals and apply resources to ending this pandemic.